Engine Biosciences
PrivateLast Round
Series A
Extension
Oct 31, 2023
Est. Valuation
$82M
Total Funding Raised
$80M
Momentum
Top 25%
of companies Caplight tracks
Company Overview
Engine Biosciences is a biotechnology company that develops precision oncology medicines and biomarkers by integrating machine learning with high-throughput biology and combinatorial genetics.
Sector
Healthcare & Life Sciences
Verticals
Drug Discovery, Biotechnology, Precision Medicine, Medical AI
Business Model
B2B
Customer Profile
Revenue Share, Services & Consulting
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Engine Biosciences Comparables
Compare Engine Biosciences with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Waypoint Bio | 88% | |
| Relation Therapeutics | 81% | |
| Nucleome Therapeutics | 80% |
Engine Biosciences Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series A Extension | Oct 31, 2023 | ||||
| Series A | May 26, 2021 | ||||
| Seed | Jan 31, 2018 |
Engine Biosciences Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Nest.Bio | Series A, Seed |
| SEEDS Capital | Series A Extension |
| Vectr Ventures | Series A |
| Camford Capital | Series A, Seed |
| Baidu Ventures | Series A, Seed |
| WI Harper Group | Series A, Seed |
| ClavystBio | Series A Extension |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jun 18, 2026
Monthly visitors increased 137% MoM.
- Jun 9, 2026
Grew 16% QoQ, from 31 to 36 employees.
Engine Biosciences Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Engine Biosciences's valuation, stock price, and market status.
Is Engine Biosciences a public or private company?
Engine Biosciences is a private company.
What is the current stock price of Engine Biosciences?
Engine Biosciences is a private company with no public stock price. No recent secondary market data is available.
How much is Engine Biosciences worth (valuation)?
Valuation information for Engine Biosciences is not publicly available.
Can I buy Engine Biosciences stock?
Engine Biosciences shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was Engine Biosciences's last funding round?
Engine Biosciences's most recent funding round was Series A Extension on October 31, 2023.
Who are the main investors in Engine Biosciences?
Key investors in Engine Biosciences include 6 Dimensions Capital, Polaris Partners, DHVC.
Will Engine Biosciences IPO soon?
No public IPO plans have been announced for Engine Biosciences.
How can I track Engine Biosciences secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Engine Biosciences's secondary market activity and sign up for updates.